Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 511 AL 525

Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial

Schurad B, Koch C, Schug B, Morte A, Vaqué A, De la Torre R, Iniesta M.

Curr Alzheimer Res. 2022;19(7):541-553. doi: 10.2174/1567205019666220823105059.

Functional diversity of apolipoprotein E: from subcellular localization to mitochondrial function

Rueter J, Rimbach G, Huebbe P.

Cell Mol Life Sci. 2022 Aug 26;79(9):499. doi: 10.1007/s00018-022-04516-7.

Quantitative trait locus (xQTL) approaches identify risk genes and drug targets from human non-coding genomes

Bykova M, Hou Y, Eng C, Cheng F.

Hum Mol Genet. 2022 Oct 20;31(R1):R105-R113. doi: 10.1093/hmg/ddac208.

A systematic review on drugs for synaptic plasticity in the treatment of dementia

Piscopo P, Crestini A, Carbone E, Rivabene R, Ancidoni A, Lo Giudice M, Corbo M, Vanacore N, Lacorte E.

Ageing Res Rev. 2022 Nov;81:101726. doi: 10.1016/j.arr.2022.101726. Epub 2022 Aug 27.

TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications

Gu Z, Cao H, Zuo C, Huang Y, Miao J, Song Y, Yang Y, Zhu L, Wang F.

Neurobiol Dis. 2022 Oct 15;173:105855. doi: 10.1016/j.nbd.2022.105855. Epub 2022 Aug 27.

γ-Secretase as a drug target for familial Alzheimer's disease: the road less traveled

Wolfe MS.

Future Med Chem. 2022 Oct;14(19):1341-1343. doi: 10.4155/fmc-2022-0178. Epub 2022 Aug 30.

Carthamus tinctorius L.: A natural neuroprotective source for anti-Alzheimer's disease drugs

Liang Y, Wang L.

J Ethnopharmacol. 2022 Nov 15;298:115656. doi: 10.1016/j.jep.2022.115656. Epub 2022 Aug 27.

Contribution of hyperglycemia-induced changes in microglia to Alzheimer's disease pathology

Hernández-Rodríguez M, Clemente CF, Macías-Pérez ME, Rodríguez-Fonseca RA, Vázquez MIN, Martínez J, Ruvalcaba RM, Rosas MM, Jiménez EM.

Pharmacol Rep. 2022 Oct;74(5):832-846. doi: 10.1007/s43440-022-00405-9. Epub 2022 Aug 31.

Neuroinflammation and Oxidative Stress in Alzheimer's Disease; Can Nutraceuticals and Functional Foods Come to the Rescue?

Onaolapo OJ, Olofinnade AT, Ojo FO, Onaolapo AY.

Antiinflamm Antiallergy Agents Med Chem. 2022;21(2):75-89. doi: 10.2174/1871523021666220815151559.

Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy

Zhang H, Peng Y, Zhuo L, Wang Y, Zeng G, Wang S, Long L, Li X, Wang Z.

Eur J Med Chem. 2022 Nov 15;242:114695. doi: 10.1016/j.ejmech.2022.114695. Epub 2022 Aug 27.

Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease

Wu L, Xian X, Xu G, Tan Z, Dong F, Zhang M, Zhang F.

Mediators Inflamm. 2022 Aug 21;2022:7924199. doi: 10.1155/2022/7924199. eCollection 2022.

Nutrients and amyloid β status in the brain: A narrative review

Díaz G, Lengele L, Sourdet S, Soriano G, de Souto Barreto P.

Ageing Res Rev. 2022 Nov;81:101728. doi: 10.1016/j.arr.2022.101728. Epub 2022 Aug 30.

Ever-expanding landscape: Alzheimer's - new targets and new patents

Egunlusi AO, Joubert J.

Pharm Pat Anal. 2022 Sep;11(5):135-138. doi: 10.4155/ppa-2022-0031. Epub 2022 Sep 2.

Electroencephalographic hallmarks of Alzheimer's disease

Ferreri F, Miraglia F, Vecchio F, Manzo N, Cotelli M, Judica E, Rossini PM.

Int J Psychophysiol. 2022 Nov;181:85-94. doi: 10.1016/j.ijpsycho.2022.08.005. Epub 2022 Aug 31.

A population-based meta-analysis of circulating GFAP for cognition and dementia risk

Gonzales MM, Wiedner C, Wang CP, Liu Q, Bis JC, Li Z, Himali JJ, Ghosh S, Thomas EA, Parent DM, Kautz TF, Pase MP, Aparicio HJ, Djoussé L, Mukamal KJ, Psaty BM, Longstreth WT Jr, Mosley TH Jr, Gudnason V, Mbangdadji D, Lopez OL, Yaffe K, Sidney S, Bryan RN, Nasrallah IM, DeCarli CS, Beiser AS, Launer LJ, Fornage M, Tracy RP, Seshadri S, Satizabal CL.

Ann Clin Transl Neurol. 2022 Oct;9(10):1574-1585. doi: 10.1002/acn3.51652. Epub 2022 Sep 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias